Showing results (141-150 of 155) with videos related to

Sort By:
Pageof 16
Molecular Psychiatry|May 25, 2026
Genetic investigation of the association between maternal dietary patterns and offspring ADHDKristina Aagaard, Casper-Emil T Pedersen, David Horner, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|October 26, 2016
TRPA1 gene polymorphisms and childhood asthmaValentina Gallo, F Nicole Dijk, John W Holloway, et al.
BMC Medicine|February 22, 2022
Determinants of pre-vaccination antibody responses to SARS-CoV-2: a population-based longitudinal study (COVIDENCE UK)Mohammad Talaei, Sian Faustini, Hayley Holt, et al.
Vaccines|October 27, 2022
Determinants of Antibody Responses to SARS-CoV-2 Vaccines: Population-Based Longitudinal Study (COVIDENCE UK)David A Jolliffe, Sian E Faustini, Hayley Holt, et al.
Chemical Science|June 15, 2018
Non-competitive cyclic peptides for targeting enzyme-substrate complexesT E McAllister, T-L Yeh, M I Abboud, et al.
Chemical Science|February 14, 2018
Molecular and cellular mechanisms of HIF prolyl hydroxylase inhibitors in clinical trialsTzu-Lan Yeh, Thomas M Leissing, Martine I Abboud, et al.
ACS Chemical Biology|July 10, 2019
The Clinically Used Iron Chelator Deferasirox Is an Inhibitor of Epigenetic JumonjiC Domain-Containing Histone DemethylasesMartin Roatsch, Inga Hoffmann, Martine I Abboud, et al.
Nature Chemical Biology|June 20, 2018
The Jumonji-C oxygenase JMJD7 catalyzes (3S)-lysyl hydroxylation of TRAFAC GTPasesSuzana Markolovic, Qinqin Zhuang, Sarah E Wilkins, et al.
Nature Chemical Biology|June 29, 2018
Publisher Correction: The Jumonji-C oxygenase JMJD7 catalyzes (3S)-lysyl hydroxylation of TRAFAC GTPasesSuzana Markolovic, Qinqin Zhuang, Sarah E Wilkins, et al.
Pageof 16